Tamsulosin hydrochloride
Tamsulosin reduces the tension of the prostate gland and urinary tract, facilitating urine flow and urination. Additionally, the medicine reduces the feeling of pressure on the urinary bladder. Tamsulosin is used in men to alleviate symptoms associated with an enlarged prostate gland (benign prostatic hyperplasia), such as: difficulty urinating (reduced urine flow), urinating in drops, sudden urge to urinate, and frequent urination, both at night and during the day.
Before starting to take Tamsiger, the patient should discuss it with their doctor or pharmacist:
The patient may notice remnants of the tablet in their stool. However, since the active substance has already been released, there is no risk that the tablet will be less effective.
Tamsiger should not be used in children and adolescents under 18 years of age, as it does not show efficacy in this patient group.
Tamsulosin may interact with other medicines, and other medicines may affect the efficacy of tamsulosin. Tamsulosin may interact with:
The patient should inform their doctor or pharmacistabout all medicines they are currently taking or have recently taken, as well as those they plan to take, including over-the-counter medicines.
Tamsiger can be taken with or without food.
Tamsulosin is not indicated for use in women.
In men, ejaculatory disorders (ejaculation disorders) have been reported, consisting of the semen not being released through the urethra but instead flowing back into the bladder (retrograde ejaculation) or being released in reduced quantity or not at all (absence of ejaculation). This phenomenon is harmless.
There is no data confirming the effect of tamsulosin on the ability to drive vehicles and operate machines. However, it should be remembered that Tamsiger may cause dizziness or feeling of emptiness in the head, so the patient should only drive vehicles and operate machines when they feel well.
This medicine should always be taken as directed by the doctor. In case of doubts, the doctor or pharmacist should be consulted.
The usual doseis one tablet per day. The medicine can be taken with or without food, preferably at the same time every day.
The tablet should be swallowed whole. It is essential not to crush or chew the tablets, as this may affect the efficacy of tamsulosin.
Tamsiger is not intended for use in children.
In case of taking a higher dose of Tamsiger than recommended, a sudden drop in blood pressure may occur. Symptoms such as dizziness, weakness, nausea, vomiting, diarrhea, and fainting may occur. The patient should lie down to reduce the effects of low blood pressure and then contact their doctor.
If the patient forgets to take the medicine at the scheduled time, they can take it later the same day. If the patient forgets to take the medicine on a given day, they should take the next dose the following day at the usual time. A double dose should not be taken to make up for the missed dose.
If the treatment with Tamsiger is stopped too early, the symptoms of the disease may return. Therefore, the medicine should be taken for as long as the doctor recommends, even if the symptoms of the disease have disappeared. Before stopping the treatment, the patient should always consult their doctor. In case of any further doubts related to the use of this medicine, the patient should consult their doctor or pharmacist.
Like all medicines, Tamsiger can cause side effects, although not everybody gets them. Serious side effects are rare. Medical help should be sought immediatelyif the patient experiences a severe allergic reaction with swelling of the face or throat(anaphylactic shock).
Common side effects(may affect up to 1 in 10 people)
Uncommon side effects(may affect up to 1 in 100 people)
Rare side effects(may affect up to 1 in 1,000 people)
Side effects with unknown frequency(frequency cannot be estimated from the available data)
Side effects can be reported directly to:
Department for Monitoring of Adverse Reactions of Medicinal Products, Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products
Jerozolimskie Avenue 181 C
02-222 Warsaw
Phone: +48 22 49 21 301
Fax: +48 22 49 21 309
Website: https://smz.ezdrowie.gov.pl
Side effects can also be reported to the marketing authorization holder. By reporting side effects, more information can be collected on the safety of the medicine.
The medicine should be stored out of sight and reach of children.
The medicine should not be used after the expiry date stated on the packaging after EXP.
The first two digits indicate the month, and the last four digits indicate the year.
The expiry date indicates the last day of the specified month.
Store in the original packaging to protect from light.
Medicines should not be disposed of via wastewater or household waste. The patient should ask their pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment.
Coating
Microcrystalline cellulose
Hypromellose
Carboxymethylcellulose silica, anhydrous
Magnesium stearate
White, round tablets with "T9SL" embossed on one side and "0.4" on the other side.
The medicine is available in blisters containing 30 or 90 tablets, in a cardboard box.
Not all pack sizes may be marketed.
G.L. Pharma GmbH
Schlossplatz 1
8502 Lannach
Austria
G.L. Pharma GmbH
Schlossplatz 1
8502 Lannach
Austria
Synthon Hispania SL
Calle Castelló 1
08830 Sant Boi de Llobregat, Barcelona
Spain
Synthon B.V.
Microweg 22
6545 CM Nijmegen
Netherlands
Genericon Pharma Gesellschaft m.b.H.
Hafnerstrasse 211
8054 Graz
Austria
Industria Química y Farmacéutica VIR, S.A.
Calle Laguna 66-68-70
Poligono Industrial Urtinsa II
28923 Alcorcón, Madrid
Spain
G.L. PHARMA POLAND Sp. z o.o.
Jana Pawła II Avenue 61/313
01-031 Warsaw, Poland
Phone: 022/ 636 52 23; 636 53 02
biuro@gl-pharma.pl
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.